Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli

Journal of Neurochemistry

Volumn 95, Issue 2, 2005, Pages 437-445

  Maresz, Katarzyna ^a   Carrier, Erica J ^b   Ponomarev, Eugene D ^a   Hillard, Cecilia J ^b   Dittel, Bonnie N ^a  

^a BLOOD RESEARCH INSTITUTE   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Cannabinoid; Central nervous system; Endocannabinoid; Experimental autoimmune encephalomyelitis; Microglial cells; Multiple sclerosis

Indexed keywords

2 ARACHIDONOYLGLYCEROL; CANNABINOID; CANNABINOID 2 RECEPTOR; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MESSENGER RNA; ARACHIDONIC ACID; COMPLEMENTARY DNA; CYTOKINE; HYBRID PROTEIN;

ADOLESCENT; ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL FUNCTION; GENE EXPRESSION; IMMUNOPATHOLOGY; INFLAMMATION; MICROGLIA; MOUSE; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR UPREGULATION; SPINAL CORD; ANIMAL; BIOSYNTHESIS; BONE MARROW CELL; C57BL MOUSE; CELL CULTURE; DRUG EFFECT; FLOW CYTOMETRY; GENETICS; ISOLATION AND PURIFICATION; MACROPHAGE; MACROPHAGE ACTIVATION; MASS SPECTROMETRY; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

ANIMALIA;

ANIMALS; ARACHIDONIC ACID; BONE MARROW CELLS; CELLS, CULTURED; CYTOKINES; DNA, COMPLEMENTARY; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FLOW CYTOMETRY; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; INFLAMMATION; INTERFERON TYPE II; MACROPHAGE ACTIVATION; MACROPHAGES; MASS SPECTROMETRY; MICE; MICE, INBRED C57BL; MICROGLIA; RECEPTOR, CANNABINOID, CB2; RECOMBINANT FUSION PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SPINAL CORD; UP-REGULATION;

EID: 26844448746     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2005.03380.x     Document Type: Article

References (57)

1. Aloisi F. (2001) Immune function of microglia. Glia 36, 165-179.
2. Arévalo-Martín A., Vela J. M., Molina-Holgado E., Borrell J. and Guaza C. (2003) Therapeutic action of cannabinoids in a murine model of multiple sclerosis. J. Neurosci. 23, 2511-2516.
3. Baker D., Pryce G., Croxford J. L. et al. (2001)Endocannabinoids control spasticity in a multiple sclerosis model. FASEB J. 15, 300-302.
4. Becher B. and Antel J. P. (1996) Comparison of phenotypic and functional properties of immediately ex vivo and cultured human adult microglia. Glia 18, 1-10.
5. 2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains. J. Neurosci. 23, 11 136-11 141.
6. 2 receptor. Eur. J. Pharmacol. 396, 141-149.
7. 2 cannabinoid receptor by rodent macrophages and macrophage-like cells in relation to cell activation. Int. Immunopharmacol. 2, 69-82.
8. 2 receptor-dependent mechanism. Mol. Pharmacol. 65, 999-1007.
9. Carson M. J. (2002) Microglia as liaisons between the immune and central nervous systems: functional implications for multiple sclerosis. Glia 40, 218-231.
10. Compston A. and Coles A. (2002) Multiple sclerosis. Lancet 359, 1221-1231.
11. Croxford J. L. and Miller S. D. (2003) Immunoregulation of a viral model of multiple sclerosis using the synthetic cannabinoid R(+)WIN55,212. J. Clin. Invest. 111, 1231-1240.
12. De Petrocellis L., Bisogno T. and Di Marzo V. (2003) Neuromodulatory actions of endocannabinoids in pain and sedation. Adv. Exp. Med. Biol. 523, 215-225.
13. Devane W. A., Hanus L., Breuer A. et al. (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258, 1946-1949.
14. Di Marzo V., Bisogno T., De Petrocellis L., Melck D., Orlando P., Wagner J. A. and Kunos G. (1999) Biosynthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in circulating and tumoral macrophages. Eur. J. Biochem. 264, 258-267.
15. Dittel B. N., Sant'Angelo D. B. and Janeway C. A., Jr (1997) Peptide antagonists inhibit proliferation and the production of IL-4 and/or IFN-γ in T helper 1, T helper 2, and T helper 0 clones bearing the same TCR. J. Immunol. 158, 4065-4073.
16. Dittel B. N., Merchant R. M. and Janeway C. A., Jr (1999) Evidence for Fas-dependent and Fas-independent mechanisms in the pathogenesis of experimental autoimmune encephalomyelitis. J. Immunol. 162, 6392-6400.
17. 2 and abnormal-cannabidiol-sensitive receptors. Eur. J. Pharmacol. 474, 195-198.
18. Freund T. F., Katona I. and Piomelli D. (2003) Role of endogenous cannabinoids in synaptic signaling. Physiol. Rev. 83, 1017-1066.
19. Galiègue S., Mary S., Marchand J., Dussossoy D., Carrière D., Carayon P., Bouaboula M., Shire D., Le Fur G. and Casellas P. (1995) Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur. J. Biochem. 232, 54-61.
20. Guillemin G. J. and Brew B. J. (2004) Microglia, macrophages, perivascular macrophages, and pericytes: a review of function and identification. J. Leukoc. Biol. 75, 388-397.
21. 1 cannabinoid receptors heterologously expressed in mammalian neurons. Mol. Pharmacol. 65, 665-674.
22. Heppner F. L., Greter M., Marino D. et al. (2005) Experimental autoimmune encephalomyelitis repressed by microglial paralysis. Nat. Med. 11, 146-152.
23. Kaminski N. E., Abood M. E., Kessler F. K., Martin B. R. and Schatz A. R. (1992) Identification of a functionally relevant cannabinoid receptor on mouse spleen cells that is involved in cannabinoid-mediated immune modulation. Mol. Pharmacol. 42, 736-742.
24. Killestein J., Uitdehaag B. M. and Polman C. H. (2004) Cannabinoids in multiple sclerosis: do they have a therapeutic role? Drugs 64, 1-11.
25. Kim D. and Thayer S. A. (2001) Cannabinoids inhibit the formation of new synapses between hippocampal neurons in culture. J. Neurosci. 21, RC146, (1-5).
26. 2 receptor-dependent mechanism. J. Biol. Chem. 278, 24 469-24 475.
27. Klein T. W., Newton C., Larsen K., Lu L., Perkins I., Nong L. and Friedman H. (2003) The cannabinoid system and immune modulation. J. Leukoc. Biol. 74, 486-496.
28. 2 receptor mRNA in mouse immune cell subpopulations and following B cell stimulation. Eur. J. Pharmacol. 423, 235-241.
29. Ling E. A. and Wong W. C. (1993) The origin and nature of ramified and amoeboid microglia: a historical review and current concepts. Glia 7, 9-18.
30. 9-tetrahydrocannabinol: a novel treatment for experimental autoimmune encephalomyelitis. J. Neuroimmunol. 23, 73-81.
31. Maestroni G. J. (2004) The endogenous cannabinoid 2-arachidonoyl glycerol as in vivo chemoattractant for dendritic cells and adjuvant for Th1 response to a soluble protein. FASEB J. 18, 1914-1916.
32. Matias I., Pochard P., Orlando P., Salzet M., Pestel J. and Di Marzo V. (2002) Presence and regulation of the endocannabinoid system in human dendritic cells. Eur. J. Biochem. 269, 3771-3778.
33. Matsuda L. A., Lolait S. J., Brownstein M. J., Young A. C. and Bonner T. I. (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346, 561-564.
34. Mechoulam R., Ben-Shabat S., Hanus L. et al. (1995) Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem. Pharmacol. 50, 83-90.
35. Mestre L., Correa F., Arévalo-Martín A., Molina-Holgado E., Valenti M., Ortar G., Di Marzo V. and Guaza C. (2005) Pharmacological modulation of the endocannabinoid system in a viral model of multiple sclerosis. J. Neurochem. 92, 1327-1339.
36. Munro S., Thomas K. L. and Abu-Shaar M. (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature 365, 61-65.
37. Nelson P. T., Soma L. A. and Lavi E. (2002) Microglia in diseases of the central nervous system. Ann. Med. 34, 491-500.
38. 2 receptors are expressed by perivascular microglial cells in the human brain: an immunohistochemical study. Synapse 53, 208-213.
39. Parolaro D., Massi P., Rubino T. and Monti E. (2002) Endocannabinoids in the immune system and cancer. Prostaglandins Leukot. Essent. Fatty Acids 66, 319-332.
40. Pertwee R. G. (2002) Cannabinoids and multiple sclerosis. Pharmacol. Ther. 95, 165-174.
41. Ponomarev E. D., Novikova M., Yassai M., Szczepanik M., Gorski J. and Dittel B. N. (2004) γδ T cell regulation of IFN-γ production by central nervous system-infiltrating encephalitogenic T cells: correlation with recovery from experimental autoimmune encephalomyelitis. J. Immunol. 173, 1587-1595.
42. Ponomarev E. B., Shriver L. P., Maresz K. and Dittel B. N. (2005a) Microglial cell activation and proliferation precedes the onset of CNS autoimmunity. J. Neurosci. Res. in press.
43. Ponomarev E. B., Novikova M., Maresz K., Shriver L. P. and Dittel B. N. (2005b) Development of a culture system that supports adult microglial cell proliferation and maintenance in the resting state. J. Immunol. Meth. 300, 32-46.
44. Porter A. C. and Felder C. C. (2001) The endocannabinoid nervous system: unique opportunities for therapeutic intervention. Pharmacol. Ther. 90, 45-60.
45. Pryce G., Ahmed Z., Hankey D. J. et al. (2003) Cannabinoids inhibit neurodegeneration in models of multiple sclerosis. Brain 126, 2191-2202.
46. Rademacher D. J., Kearn C. S., Carrier E. J. et al. (2004) Production of hydroxyeicosatetraenoic acids and prostaglandins by a novel rat microglial cell line. J. Neuroimmunol. 149, 130-141.
47. Saario S. M., Savinainen J. R., Laitinen J. T., Järvinen T. and Niemi R. (2004) Monoglyceride lipase-like enzymatic activity is responsible for hydrolysis of 2-arachidonoylglycerol in rat cerebellar membranes. Biochem. Pharmacol. 67, 1381-1387.
48. Schmid P. C., Zuzarte-Augustin M. L. and Schmid H. H. (1985) Properties of rat liver N-acylethanolamine amidohydrolase. J. Biol. Chem. 260, 14 145-14 149.
49. Sugiura T., Kondo S., Sukagawa A., Nakane S., Shinoda A., Itoh K., Yamashita A. and Waku K. (1995) 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem. Biophys. Res. Commun. 215, 89-97.
50. 2 receptor. Comparison of the agonistic activities of various cannabinoid receptor ligands in HL-60 cells. J. Biol. Chem. 275, 605-612.
51. Sugiura T., Kobayashi Y., Oka S. and Waku K. (2002) Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance. Prostaglandins Leukot. Essent. Fatty Acids 66, 173-192.
52. Walter L., Franklin A., Witting A., Wade C., Xie Y., Kunos G., Mackie K. and Stella N. (2003) Nonpsychotropic cannabinoid receptors regulate microglial cell migration. J. Neurosci. 23, 1398-1405.
53. Wilson R. I. and Nicoll R. A. (2001) Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature 410, 588-592.
54. Wirguin I., Mechoulam R., Breuer A., Schezen E., Weidenfeld J. and Brenner T. (1994) Suppression of experimental autoimmune encephalomyelitis by cannabinoids. Immunopharmacology 28, 209-214.
55. G93A transgenic mice. J. Neurochem. 89, 1555-1557.
56. Woodroofe M. N., Sarna G. S., Wadhwa M., Hayes G. M., Loughlin A. J., Tinker A. and Cuzner M. L. (1991) Detection of interleukin-1 and interleukin-6 in adult rat brain, following mechanical injury, by in vivo microdialysis: evidence of a role for microglia in cytokine production. J. Neuroimmunol. 33, 227-236.
57. 2 receptor expression in the rat spinal cord of neuropathic but not inflammatory chronic pain models. Eur. J. Neurosci. 17, 2750-2754.